Phosphate Therapeutics

Phosphate Therapeutics

Development of mineral-derived hospital pharmaceuticals.

HQ location
Gateshead, United Kingdom
Launch date
Market cap
$42.6m
Enterprise value
$62m
Share price
£0.03 STX.L
Company register number
  • Edit
loading funding rounds…

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
GBP2021202220232024202520262027
Revenues0000000000000000000000000000
% growth(85 %)194 %122 %146 %68 %50 %28 %
EBITDA0000000000000000000000000000
% EBITDA margin(1142 %)(506 %)(231 %)(66 %)(16 %)4 %25 %
Profit0000000000000000000000000000
% profit margin(1273 %)(905 %)(254 %)(84 %)(29 %)(4 %)32 %
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue38 %24 %14 %6 %---

Source: Company filings or news article, Equity research estimates

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo